An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users (Q46058170)

19 December 2017

title

An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users (English)

1 reference

19 December 2017

1 reference

A Pirona

1

1 reference

19 December 2017

M J Morgan

series ordinal

2

1 reference

19 December 2017

language of work or name

English

0 references

publication date

7 April 2009

1 reference

19 December 2017

Journal of Psychopharmacology

published in

1 reference

19 December 2017

volume

24

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

175-185

1 reference

19 December 2017

Insensitivity to future consequences following damage to human prefrontal cortex

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Neurocognitive consequences of sleep deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Memory deficits associated with recreational use of "ecstasy" (MDMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

21 January 2018

Identifiers

DOI

10.1177/0269881109102780

1 reference

19 December 2017

PubMed ID

19351799

1 reference

19 December 2017